Imunon Appoints Former CFO Jeffrey Church as Interim CFO Following Kimberly Graper's Resignation

summarizeSummary

Imunon, Inc. announced the resignation of its interim Chief Financial Officer, Kimberly Graper, and the immediate appointment of former CFO Jeffrey Church to the interim role, ensuring continuity in financial leadership.

check_boxKey Events

• Interim CFO Resignation

  Kimberly Graper resigned from her role as interim Chief Financial Officer, effective January 14, 2026, to pursue another career opportunity. The company stated her departure was without any disagreements with management.

• Interim CFO Appointment

  Jeffrey Church, the company's former Executive Vice President, Chief Financial Officer, and Corporate Secretary, was appointed as interim Chief Financial Officer, effective January 14, 2026. Mr. Church had been in a consulting role since his retirement in May 2024.

• Consulting Agreement Amended

  Mr. Church's consulting agreement was amended to provide a monthly retainer of $30,000, plus an additional $250 for each hour of services performed in excess of 40 hours per month during an extended consulting period.

auto_awesomeAnalysis

Imunon, a micro-cap company, announced a change in its interim Chief Financial Officer role. While the departure of Kimberly Graper, even for another opportunity, introduces some uncertainty, the immediate appointment of Jeffrey Church, a former Executive VP and CFO of the company, provides crucial continuity. Mr. Church's extensive prior experience with Imunon and other life science companies is a positive factor, mitigating the potential disruption of an executive transition. The compensation structure for Mr. Church reflects the importance of this role for the company.